LAVAL, Quebec, March 15, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX andTSX: VRX ) ("Valeant" or the "Company") wholly owned subsidiary Bausch + Lomb, a leading global eye health company, today announced the introduction of Biotrue ® ONEday for Astigmatism daily disposable contact lenses. Approximately 73.2 million people in the U.S. are astigmatic, but only 8.8 million people are currently wearing toric contact lenses. 1 Biotrue ® ONEday for Astigmatism helps eye care practitioners capture this astigmatic opportunity by offering patients the convenience of a daily disposable contact lens with the innovation of an evolved peri-ballast design for stability and a unique dehydration barrier to help the lens maintain 98% of its moisture for up to 16 hours. 1